| 000 | 01778 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516101540.0 | ||
| 264 | 0 | _c20130619 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mds133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuddy, K J | |
| 245 | 0 | 0 |
_aPersistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cDec 2012 |
||
| 300 |
_a3075-3081 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
| 650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedication Adherence |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aPatient Compliance |
| 700 | 1 | _aPitcher, B N | |
| 700 | 1 | _aArcher, L E | |
| 700 | 1 | _aCohen, H J | |
| 700 | 1 | _aWiner, E P | |
| 700 | 1 | _aHudis, C A | |
| 700 | 1 | _aMuss, H B | |
| 700 | 1 | _aPartridge, A H | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 23 _gno. 12 _gp. 3075-3081 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mds133 _zAvailable from publisher's website |
| 999 |
_c21922551 _d21922551 |
||